MedTrace Logo

Acute Hemodynamic and Biological Effects of ECP and Exercise

NCT02014090 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-12-17

No results posted yet for this study

Summary

The purpose of this study in humans with stable coronary artery disease (CAD) treatable by percutaneous intervention (PCI) is to evaluate the efficacy of Enhanced External Counterpulsation (EECP) with regard to coronary collateral growth.

Conditions

  • Patients With Stable Coronary Artery Disease

Interventions

OTHER

Hemodynamic and biological measurements

by MCE, PWA, Doppler, Multiplex, FACS

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Steffen Gloekler, MD · University of Bern

  • Stefano de Marchi, MD · University of Bern

  • Stefano Rimoldi, MD · University of Bern

  • Christian Seiler, MD · University of Bern

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02014090 on ClinicalTrials.gov